BRIERLEY PARK MEDICAL GROUP — All Prescriptions & Medications — Page 12
Practice Code: C84077 | SUTTON-IN-ASHFIELD, NG17 2NF
Showing results 551-600 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nystatin | 24 | 900 | £271 | +759.2% ▲ |
| Dapsone | 23 | 518 | £124 | +122.6% ▲ |
| Other calcium supplement preparations | 23 | 2,020 | £905 | +206.7% ▲ |
| Mefenamic acid | 23 | 708 | £132 | -49.1% ▼ |
| 23 | 396 | £192 | +92.9% ▲ | |
| 23 | 670 | £458 | -11.7% ▼ | |
| Cenobamate | 22 | 616 | £3.1K | -9.2% ▼ |
| Insulin glulisine | 22 | 141 | £799 | +2.6% ▲ |
| 22 | 660 | £3.2K | -51.3% ▼ | |
| 22 | 295 | £278 | -69.5% ▼ | |
| Co-tenidone (Atenolol/chlortalidone) | 21 | 588 | £51 | +0.7% vs avg |
| Telmisartan | 21 | 980 | £113 | -63.8% ▼ |
| Ofloxacin | 21 | 367 | £520 | +155.6% ▲ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 21 | 486 | £1.1K | +111.5% ▲ |
| Fusidic acid | 21 | 105 | £404 | +103.3% ▲ |
| 21 | 130 | £267 | +78.1% ▲ | |
| 21 | 810 | £1.4K | +64.1% ▲ | |
| 21 | 16.3K | £2.3K | -46.6% ▼ | |
| Dexamethasone sodium metasulphobenzoate | 20 | 192 | £171 | +169.1% ▲ |
| 20 | 325 | £863 | +86.5% ▲ | |
| 20 | 114 | £285 | +240.1% ▲ | |
| 20 | 549 | £223 | -1.1% vs avg | |
| 20 | 440 | £1.0K | -4.2% ▼ | |
| Riluzole | 19 | 1,064 | £5.4K | +83.1% ▲ |
| Soluble insulin (Neutral insulin) | 19 | 55 | £329 | +97.2% ▲ |
| Fluorometholone | 19 | 105 | £33 | +31.9% ▲ |
| Ketorolac trometamol | 19 | 105 | £80 | +104.8% ▲ |
| Benzoyl peroxide | 19 | 1,050 | £184 | +34.8% ▲ |
| 19 | 190 | £465 | +61.6% ▲ | |
| 19 | 120 | £311 | +30.1% ▲ | |
| Balsalazide sodium | 18 | 1,926 | £429 | +20.8% ▲ |
| Formoterol/glycopyrronium/budesonide | 18 | 18 | £761 | -70.1% ▼ |
| Mebendazole | 18 | 488 | £26 | +57.2% ▲ |
| Goserelin acetate | 18 | 18 | £3.8K | -59.1% ▼ |
| Powder 20g GMP protein equivalent (0913205) | 18 | 540 | £8.5K | +86.4% ▲ |
| Gel OTC glucose for diabetic hypo treatment (0913541) | 18 | 1,998 | £188 | +50.8% ▲ |
| Nabumetone | 18 | 1,204 | £349 | +29.4% ▲ |
| Ivermectin | 18 | 840 | £487 | -15.3% ▼ |
| Hepatitis B | 18 | 18 | £186 | +70.1% ▲ |
| 18 | 281 | £1.0K | +173.8% ▲ | |
| 18 | 210 | £187 | -42.2% ▼ | |
| 18 | 560 | £139 | +22.3% ▲ | |
| 18 | 33.3K | £3.9K | -34.1% ▼ | |
| Hydralazine hydrochloride | 17 | 1,260 | £66 | -59.7% ▼ |
| Bempedoic acid | 17 | 476 | £896 | -48.1% ▼ |
| Citalopram hydrochloride | 17 | 255 | £186 | +5.9% ▲ |
| Ferrous gluconate | 17 | 504 | £14 | -64.5% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 17 | 288.8K | £7.2K | +23.1% ▲ |
| Powder 1.4 kcal/ml milkshake (0913021) | 17 | 308 | £389 | +275.2% ▲ |
| Azelastine hydrochloride | 17 | 136 | £104 | +43.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.